NCT05189327 (NUCaCD) is a clinical trial of No intervention in Ulcerative Colitis Chronic, sponsored by Kazakhstan Scientific Society for Study of intestine diseases.

Who is sponsoring NCT05189327?

NCT05189327 is sponsored by Kazakhstan Scientific Society for Study of intestine diseases.

What drugs are being tested in NCT05189327?

Interventions in NCT05189327: No intervention.

What condition does NCT05189327 study?

NCT05189327 studies Ulcerative Colitis Chronic, Crohn Disease Colon.

Is NCT05189327 still recruiting?

NCT05189327 is currently status unknown. Last updated 12 January 2022.

Last reviewed 2022-01-12 · How we verify

NCT05189327: NUCaCD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Noninterventional Observational Prospective Longitudinal Study of the Incidence of Ulcerative Colitis and Crohn's Disease Among the Adult Population of the Republic of Kazakhstan

Status unknown Last updated 12 January 2022

What this trial tests

trial testing No intervention in Ulcerative Colitis Chronic in 2,000 participants. Status unknown.

Timeline

10 December 2021

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	Kazakhstan Scientific Society for Study of intestine diseases
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	2,000
Start date	10 December 2021
Primary completion	31 December 2024
Estimated completion	31 December 2024
Sites	1 location across Kazakhstan

Drugs / interventions tested

No intervention

Conditions studied

Ulcerative Colitis Chronic — all drugs for Ulcerative Colitis Chronic →
Crohn Disease Colon — all drugs for Crohn Disease Colon →

Sponsor

Kazakhstan Scientific Society for Study of intestine diseases

Who can join

18 and older, any sex, with Ulcerative Colitis Chronic or Crohn Disease Colon. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The NUCaCD study aims to develop a reliable registry of patients suffering inflammatory bowel diseases in the Republic of Kazakhstan.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05189327 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kazakhstan Scientific Society for Study of intestine diseases
Last refreshed: 12 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05189327.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing